Yingsheng Biology is a human genetic and molecular diagnostic technology developer.
Yingsheng Biotechnology Co., Ltd. (referred to as Yingsheng Bio) was established in 2009, and is committed to the application of molecular diagnostic techniques such as maternal and child health, neonatal genetic diseases, metabolic diseases, birth defects and other human genetics, and national eugenics engineering. Yingsheng's product line includes 45 innovative genetic metabolic disease screening reagents, 14 vitamins determination reagents, mass spectrometer automatic intelligent processing platform, and ultra-high performance liquid chromatography tandem mass spectrometry detection system. level.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 29, 2022 | Series C | — | 3 | — | — | Detail |
Nov 12, 2020 | Series B | — | 1 | — | — | Detail |
Jul 21, 2018 | Series A | — | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Huiyi Xinxi | — | Series C |
Jingming Capital | — | Series C |
Sunz Fund | — | Series C |
Ronghui Capital | — | Series B |
Source Capital | — | Series A |
Yahui Precision Medicine Fund | — | Series A |